Memory B cell development but not germinal center formation is impaired by in vivo blockade of CD40-CD40 ligand interaction.
Open Access
- 1 July 1994
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 180 (1) , 141-155
- https://doi.org/10.1084/jem.180.1.141
Abstract
To study the role of the CD40-CD40 ligand interaction in the development of memory B cells and its level of action during primary antibody responses in vivo, mice were injected with a soluble CD40 fusion protein (sCD40-gamma 1), so as to block the interaction. The effects of the treatment on the primary antibody response were reminiscent of hyper-immunoglobulin M (IgM) syndrome (HIMG1): antigen-specific IgG responses were grossly inhibited whereas the IgM response was augmented severalfold. The latter observation suggests that there is a T-dependent, CD40 ligand-independent pathway of B cell activation that leads to IgM responses and that a significant component of the IgM in HIMG1 patients is derived from T-dependent responses. The secondary response was not readily blocked by sCD40-gamma 1 treatment, indicating a relative independence of CD40 ligation of antigen-experienced B cells. The most striking finding from these studies is that the development of memory B cell populations (measured by adoptive transfer) is grossly impaired by administration of sCD40-gamma 1 during the early induction phase of the response. It is surprising that although the generation memory is diminished, there is no quantitative difference in the development of germinal centers. Whereas entry of B cells into the memory cell pathway is dependent on CD40 ligation, the clonal expansion of the potential memory precursors in germinal centers seems not to require a CD40 signal.Keywords
This publication has 50 references indexed in Scilit:
- T Cell-Dependent B Cell ActivationAnnual Review of Immunology, 1993
- B lymphocytes in vivo fail to prime naive T cells but can stimulate antigen-experienced T lymphocytes.The Journal of Experimental Medicine, 1993
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion.The Journal of Experimental Medicine, 1992
- Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's diseaseCell, 1992
- Maturation of the immune response in germinal centersCell, 1991
- Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosisEuropean Journal of Immunology, 1991
- Activation of human B lymphocytes through CD40 and interleukin 4European Journal of Immunology, 1989
- Synergistic interaction between interleukin 4 and anti-Bp50 (CDw40) revealed in a novel B cell restimulation assayEuropean Journal of Immunology, 1987
- Hyper Immunoglobulin M Immunodeficiency (Dysgammaglobulinemia)Journal of Clinical Investigation, 1979